1. Alberti KG, Eckel RH, Grundy SM et al. International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the study of Obesity. Circulation 2009 Oct 20; 120 (16): 1640-1645
2. G V Ramesh Prasad. Metabolic syndrome and chronic kidney disease: current status and future directions. World journal of Nephrology Nov 6, 2014; 3(4): 210-219
3. Browmik D, Tiwari SC. Metabolic syndrome and chronic kidney disease. Indian J Nephrol 2008 Jan; 18 (1):1-4
4. Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in metabolic syndrome. J Am Soc Nephrol 2006 Apr; 17(4 Suppl 2): 81-85
5. Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999 Sep; 56 (3): 860-872
6. Moreno-Manzano V, Ishikawa X, Lucio-Cazana J, Kitamura M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. JBiol Chemistry 2000 Apr 28; 275(17): 12684-12691
7. Serra A, Romero R, Lopez D, Navarro M et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008 Apr; 73 (8): 947-955
8. Cao Z, Cooper ME. Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 2001; 21 (6): 554-562
9. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am JPhysiol Renal Physiol 2007; 292 (1): F423-429
10. Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev 2010; 26 (1): 26-32
11. Thomas G, Sehgal AR, Kashyap SR et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clinical JAmSocNephrol 2011; 6(10): 2364-2373
12. Ryu S, Chang X, Woo HY et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009; 53 (1): 59-69
13. Bonnet F, Marre M, Halimi JM et al, DESIR Study. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. Group. J Hypertension 2006; 24 (6): 1157-1163
14. Palaniappan L, Carnethon M, Fortmann SP Association between microalbuminuria and the metabolic syndrome: NHANES III. Am JHypertension 2003; 16 (11 Pt 1): 952-958
15. Alexander MP, Patel TV, Farag YM et al. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am JKidney Dis 2009; 53 (5): 751-759
16. Buscemi S, Verga S, Batsis JA et al. Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Research Clinical Practice 2009; 86 (3): 177-185
17. Литвин А. Микроальбуминурия: клиническое значение. Врач 2011; 9: 7-13.
18. Клиническое руководство по ультразвуковой диагностике (в 2-х томах под ред. В.В.Митькова). 1 том, М.: Видар, 1996, 336 с.
19. Celermajer DS. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 1998; 32 (Suppl.)3:S29-32
20. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17: 191-195
21. Praga M. Obesity - a neglected culprit in renal disease. Nephrol Dial Transplant 2002; 17:1157-1159
22. Лындина МЛ, Шишкин АН, Тесля ОВ. Особенности ранней диагностики эндотелиальной дисфункции у больных с метаболически мсиндромом. Вестник С.-Петерб. у-та. Серия 2014; Выпуск 3: 56-65.
23. Шишкин АН, Лындина МЛ. Эндотелиальная дисфункция, метаболический синдром и микроальбуминурия. Нефрология 2009; 13(3): 24-32
24. Jassal SK, Langenberg C, vonMulen D, Bergstrom О et al. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men > 40 years of age (from the Rancho Bernardo Study). Am О Cardiol 2008; 101: 1275-1280
25. Шестакова МВ. Дисфункция эндотелия - причина или следствие метаболического синдрома? РМЖ 2001; 9 (2): 88-90
26. Lippincot MF, Carlow A, Desai A, Blum A, Rodrigo M et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. The Am Coll of Cardiol 2008; 102, (issue 3) 83-122
Послать статью по эл. почте 